Bottles of Duloxetine delayed-release capsules await labeling on the production line inside the packaging unit at the Lupin Ltd. pharmaceutical plant in Goa, India (Photographer Dhiraj Singh/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy